Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04919395
Other study ID # HUM00172715
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 16, 2021
Est. completion date June 23, 2021

Study information

Verified date January 2024
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial is being completed to understand how the study "Clip" device works when assisting clinicians with Nexplanon removals. The study device clips to the skin to hold the implant still and raise the tip of the implant during removal. The study device may improve the process for removing under arm implants by decreasing procedure time and improving the ease and safety of the procedure. The results from this study will help the researchers understand whether the study device has the potential to simplify the removal procedure and make this form of birth control safer for patients.


Recruitment information / eligibility

Status Terminated
Enrollment 4
Est. completion date June 23, 2021
Est. primary completion date June 16, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria: - Currently using Nexplanon and requesting removal - Qualifies for outpatient removal - Ability to understand and sign informed consent Exclusion Criteria: - Pregnancy - Any rashes or skin conditions around the insertion site - Known allergy to lidocaine - Known allergy to biocompatible plastics or stainless steel

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Clip device for Nexplanon Removal
The clip device will be used to assist in the removal procedure to remove the Nexplanon implant from the subject.
Procedure:
Standard of Care procedure
The participants Nexplanon will be removed per standard of care.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan VentureWell

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to remove the contraceptive implant device The amount of time that it takes to remove the contraceptive implant will be noted for both groups. During the intervention/procedure/surgery
Primary Length of incision used for the removal of the single rod contraceptive implant device This will be recorded for both groups. During the intervention/procedure/surgery
Secondary Pain based on the Wong-Baker FACES Pain rating scale from the removal of single rod contraceptive Participants will be asked to rate the pain they experienced during the procedure.
Subjects will choose the face that best illustrates the pain they experienced during the procedure. Each face corresponds to a value on a 0-10 scale, with a higher score corresponding to more pain.
During the intervention/procedure/surgery
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A